AMPH
NASDAQ · Pharmaceuticals
Amphastar Pharmaceuticals In
$18.81
-0.60 (-3.09%)
Open$19.51
Previous Close$19.41
Day High$19.66
Day Low$18.70
52W High$31.26
52W Low$16.65
Volume—
Avg Volume665.1K
Market Cap829.39M
P/E Ratio10.47
EPS$1.67
SectorPharmaceuticals
Analyst Ratings
Sell
12 analysts
Price Target
+244.1% upside
Current
$18.81
$18.81
Target
$64.73
$64.73
$41.78
$64.73 avg
$94.19
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 621.97M | 550.46M | 348.56M |
| Net Income | 84.75M | 67.51M | 62.09M |
| Profit Margin | 13.6% | 13.0% | 17.8% |
| EBITDA | 133.92M | 112.60M | 110.01M |
| Free Cash Flow | — | — | 39.29M |
| Rev Growth | +13.0% | +13.0% | -2.5% |
| Debt/Equity | 0.77 | 0.77 | 0.21 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |